October 27, 2014 by Alexander Soule
Globus Medical acquires Transplant Technologies of Texas, a provider of bone allografts, biomaterials and soft tissue products, for an unspecified amount.
Globus Medical (NYSE:GMED) said it acquired Transplant Technologies of Texas, a San Antonio-based provider of bone allografts, biomaterials and soft tissue products, for an unspecified amount.
Transplant Technologies of Texas processes sterile human tissue and distributes allograft implants including machined spine implants, demineralized bone matrix, sponge allografts and traditional bone allografts. TTOT also processes and distributes sports medicine tendons, birth tissue allografts, and dermal allografts.
Founded in 1993, TTOT claims that its products have been used in more than 600,000 implant procedures.
“TTOT’s products and capabilities will better position Globus in existing allograft markets while also providing a dedicated source of supply for our extensive pipeline of products utilizing human allograft tissue,” said David Paul, CEO of Audubon, Pa.-based Globus Medical, in prepared remarks.
